Everything we do begins with research that is unbiased and objective.

We help our clients understand how the healthcare policy landscape and markets are evolving based on our assessment of the inputs. We identify trends early.

Expert Policy Knowledge & Analysis

  • Succinct, on-going, bulleted reports detailing legislation and other policy inputs, industry impact for all sectors of healthcare (biopharma, managed care, hospitals, med tech, clinical labs & diagnostics, PBM) – in real legislative time
  • The bottom line is always on top with Our Take & Next Up
  • Additional salient details with pertinent sources and background are always provided

Healthcare Policy Industry & Due Diligence

  • Our due diligence engagements help organizations and investors take a deep dive into industries and/or technology of interest to assess policy risks and opportunities

  • Sector examples include Women’s Health, Pharmaceutical Compounding, Most Favored Nations, Tariffs

Capital Markets

  • Analyze quarterly earnings calls and financials, real-time feedback of key leadership commentary on policy and other competitor healthcare and delivery trends
  • Industries include clinical lab/diagnostics, medtech, biotech & pharma, hospitals, managed care, value-based care

Competitive Intelligence

  • Aid C-suites in their understanding of what others in their space are publicly reporting and presenting, as well as other trends
  • Prepare for IR days, quarterly earnings calls
  • Analysis of key policy issues and how markets and stakeholders view an issue, timeline, and outcome
  • Examples include managed care & insurance coverage policies, value-based care & immunology (lupus, MS)

Commercialization Plan Development

  • Aid academic researchers, early-stage biotech and medtech companies and investors to understand regulatory processes and potential hurdles
  • Project TAM
  • Perform Competitive Analysis
  • Provide IP & partnership strategy: obtaining patents and securing investment
  • Identify regulatory hurdles
  • Illuminate policies that may impact a technology’s success e.g., delivery mechanism, health equity considerations, novel technology
  • Examples include COPD, Zika Vaccine, Glioblastoma, Liquid Biopsy, Glaucoma, C. Diff, MASH

Let’s discuss your business technology or platform so we can identify relevant policy catalysts on the horizon.

Then, we can identify reimbursement & regulatory headwinds or tailwinds, as well as relevant competitive dynamics.